249 related articles for article (PubMed ID: 35867754)
1. RNA m
Wu Y; Chen Z; Xie G; Zhang H; Wang Z; Zhou J; Chen F; Li J; Chen L; Niu H; Wang H
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2119038119. PubMed ID: 35867754
[TBL] [Abstract][Full Text] [Related]
2. N
Li Z; Peng Y; Li J; Chen Z; Chen F; Tu J; Lin S; Wang H
Nat Commun; 2020 May; 11(1):2578. PubMed ID: 32444598
[TBL] [Abstract][Full Text] [Related]
3. The Molecular Basis of Human ALKBH3 Mediated RNA N
Zhang L; Duan HC; Paduch M; Hu J; Zhang C; Mu Y; Lin H; He C; Kossiakoff AA; Jia G; Zhang L
Angew Chem Int Ed Engl; 2024 Feb; 63(7):e202313900. PubMed ID: 38158383
[TBL] [Abstract][Full Text] [Related]
4. Programmable RNA N
Xie S; Jin H; Yang F; Zheng H; Chang Y; Liao Y; Zhang Y; Zhou T; Li Y
Angew Chem Int Ed Engl; 2021 Sep; 60(36):19592-19597. PubMed ID: 34081827
[TBL] [Abstract][Full Text] [Related]
5. Small Molecule-Inducible and Photoactivatable Cellular RNA N1-Methyladenosine Editing.
Xie G; Lu Y; He J; Yang X; Zhou J; Yi C; Li J; Li Z; Asadikaram G; Niu H; Xiong X; Li J; Wang H
Angew Chem Int Ed Engl; 2024 Apr; ():e202320029. PubMed ID: 38591694
[TBL] [Abstract][Full Text] [Related]
6. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs.
Chen Z; Qi M; Shen B; Luo G; Wu Y; Li J; Lu Z; Zheng Z; Dai Q; Wang H
Nucleic Acids Res; 2019 Mar; 47(5):2533-2545. PubMed ID: 30541109
[TBL] [Abstract][Full Text] [Related]
7. Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A.
Gu X; Zhuang A; Yu J; Yang L; Ge S; Ruan J; Jia R; Fan X; Chai P
Nucleic Acids Res; 2024 Mar; 52(5):2273-2289. PubMed ID: 38118002
[TBL] [Abstract][Full Text] [Related]
8. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells.
Ueda Y; Ooshio I; Fusamae Y; Kitae K; Kawaguchi M; Jingushi K; Hase H; Harada K; Hirata K; Tsujikawa K
Sci Rep; 2017 Feb; 7():42271. PubMed ID: 28205560
[TBL] [Abstract][Full Text] [Related]
9. Research progress of N1-methyladenosine RNA modification in cancer.
Liu Y; Zhang S; Gao X; Ru Y; Gu X; Hu X
Cell Commun Signal; 2024 Jan; 22(1):79. PubMed ID: 38291517
[TBL] [Abstract][Full Text] [Related]
10. Human ALKBH3-induced m
Woo HH; Chambers SK
Biochim Biophys Acta Gene Regul Mech; 2019 Jan; 1862(1):35-46. PubMed ID: 30342176
[TBL] [Abstract][Full Text] [Related]
11. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
12. The essential roles of m
Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome.
Li X; Xiong X; Wang K; Wang L; Shu X; Ma S; Yi C
Nat Chem Biol; 2016 May; 12(5):311-6. PubMed ID: 26863410
[TBL] [Abstract][Full Text] [Related]
14. ALKBH3 partner ASCC3 mediates P-body formation and selective clearance of MMS-induced 1-methyladenosine and 3-methylcytosine from mRNA.
Wollen KL; Hagen L; Vågbø CB; Rabe R; Iveland TS; Aas PA; Sharma A; Sporsheim B; Erlandsen HO; Palibrk V; Bjørås M; Fonseca DM; Mosammaparast N; Slupphaug G
J Transl Med; 2021 Jul; 19(1):287. PubMed ID: 34217309
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells.
Li XD; Wang MJ; Zheng JL; Wu YH; Wang X; Jiang XB
Cancer Sci; 2021 Nov; 112(11):4543-4552. PubMed ID: 34390075
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.
Esteve-Puig R; Climent F; Piñeyro D; Domingo-Domènech E; Davalos V; Encuentra M; Rea A; Espejo-Herrera N; Soler M; Lopez M; Ortiz-Barahona V; Tapia G; Navarro JT; Cid J; Farré L; Villanueva A; Casanova I; Mangues R; Santamarina-Ojeda P; Fernández AF; Fraga MF; Piris MA; Kol N; Avrahami C; Moshitch-Moshkovitz S; Rechavi G; Sureda A; Esteller M
Blood; 2021 Feb; 137(7):994-999. PubMed ID: 32915956
[No Abstract] [Full Text] [Related]
17. LncRNA ALKBH3-AS1 enhances ALKBH3 mRNA stability to promote hepatocellular carcinoma cell proliferation and invasion.
Lu Q; Wang H; Lei X; Ma Q; Zhao J; Sun W; Guo C; Huang D; Xu Q
J Cell Mol Med; 2022 Oct; 26(20):5292-5302. PubMed ID: 36098205
[TBL] [Abstract][Full Text] [Related]
18. m
Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
[TBL] [Abstract][Full Text] [Related]
19. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.
Li A; Cao C; Gan Y; Wang X; Wu T; Zhang Q; Liu Y; Yao L; Zhang Q
Clin Transl Med; 2022 Jun; 12(6):e906. PubMed ID: 35678231
[TBL] [Abstract][Full Text] [Related]
20. m
Takemoto S; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
